OTCMKTS:BVNRY Bavarian Nordic Q3 2026 Earnings Results & Report $11.68 -0.11 (-0.93%) As of 09:45 AM Eastern Bavarian Nordic reported Q3 2026 earnings on November 13, 2026. The company reported EPS of $0.28. Research:ProfileEarnings History Earnings Announcement Details QuarterQ3 2026Report DateNovember 13, 2026TimeBefore Market Opens Bavarian Nordic EPS ResultsActual EPS$0.28Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate3 of last 4 quartersBavarian Nordic Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Bavarian Nordic Q3 2026 Earnings FAQ Did Bavarian Nordic beat earnings estimates for Q3 2026? Bavarian Nordic (OTCMKTS:BVNRY) reported earnings of $0.28 per share for Q3 2026. The report was announced on Friday, November 13, 2026. Bavarian Nordic Earnings HeadlinesBavarian Nordic beats Q3 revenue expectationsNovember 13 at 2:15 AM | reuters.comBavarian Nordic Awarded 4 Year Mpox And Smallpox Vaccine Supply Contract By UK GovernmentNovember 2, 2026 | rttnews.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 13 at 1:00 AM | Behind the Markets (Ad)Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK governmentNovember 2, 2026 | reuters.comBavarian Nordic to provide over 200K Mpox shots to global emergency stockpileOctober 27, 2026 | msn.comBavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpileOctober 27, 2026 | reuters.comSee More Bavarian Nordic Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bavarian Nordic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bavarian Nordic and other key companies, straight to your email. Email Address About Bavarian NordicBavarian Nordic (OTCMKTS:BVNRY) is a Danish biotechnology company that develops, manufactures and markets vaccines for infectious diseases and cancer immunotherapy. Founded in 1994, the company is based in Denmark and serves markets in Europe, North America and other regions. Its best-known vaccine is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, for protection against smallpox and mpox. Bavarian Nordic also offers vaccines for diseases including rabies, tick-borne encephalitis, typhoid fever and cholera. The company uses its MVA-BN technology in vaccine development and supplies products to public health authorities as well as commercial markets. Its portfolio includes vaccines developed in-house and products added through acquisitions.View Bavarian Nordic ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco's Record $30 Dividend Shows Just How Strong Its Cash Machine IsLightPath Technologies' Record Backlog Highlights a Bigger Defense OpportunityThese 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went ShoppingGolden Dome’s $185 Billion Question: Who Actually Gets Paid?3 Pharmaceutical Stocks That Offer Safety and Growth Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
